Researchers identify protein that could cut spread of shingles
By
Haymarket Media
Oct 23, 2006
A single human protein appears to help spread of varicella-zoster virus, the cause of both shingles and chickenpox, according to researchers at the National Institutes of Health.
Telehealth option integrated with Uber Health
By
Elizabeth Newman
Jul 31, 2019
Henry Schein Medical, exclusive distributor of Medpod Inc., has said its Medpod® MobileDoc® 2 is integrated with Uber Health.
Sunrise reaches settlement with SEC, no civil penalties imposed
Jul 26, 2010
Sunrise Senior Living Inc., which has been under investigation for problematic accounting practices, has reached a settlement with the Securities and Exchange Commission.
Sun lowers earnings forecast for 2009
Sep 10, 2009
Sun Healthcare Group Inc. has altered its earnings forecast downward for 2009 as a result of the estimated impact of changes to Medicare and Medicaid reimbursement.
Manor Care sale completed
Jan 02, 2008
Following weeks of delay, The Carlyle Group, a global private equity firm, completed the sale of Manor Care Inc. for $6.3 billion, including debt.
Value is new SNF mandate
By
John O'Connor
May 01, 2014
Long-term care operators will face additional pressure to improve, said William Shrank, Ph.D., chief scientific officer for CVS/Caremark.
Leaping ahead
Feb 04, 2008
Tips and traps of clinical reimbursement documentation will be under discussion during a free McKnight’s webcast Feb. 29. The hour-long event will deal with MDS documentation “hot spots,”...
Sunrise REIT sold for $1.97 billion
By
Haymarket Media
Apr 20, 2007
The board of Sunrise Real Estate Investment Trust Thursday approved the sale of the company to Ventas Inc. The $1.97 billion purchase follows weeks of court filings and negotiations.
Ziegler announces closing of bond for Buckingham Senior Living
Oct 21, 2014
Ziegler has announced the closing of an $18.6 million bond for Buckingham Senior Living Community Inc. Senior Quality Lifestyles Corporation, a Texas not-for-profit organization, serves as the sole corporate...
Additional review time requested for ulcerative colitis drug
Dec 13, 2017
Pfizer Inc. said Tuesday the Food and Drug Administration has extended the action date by three months for the supplemental New Drug Application (sNDA) for XELJANZ®(tofacitinib) .